Latest chemotherapy Stories
DALLAS and NEW YORK, March 5, 2015 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc.
-- Potent killing of highly resistant adult and pediatric brain cancer cells SYDNEY, March 4, 2015 /PRNewswire/ -- Australian/US biotechnology company, Novogen Limited (ASX:NRT; NASDAQ:NVGN),
Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. Sacramento,
NEW YORK, March 3, 2015 /PRNewswire/ -- Delcath Systems, Inc.
Study to Enroll 20 More Subjects PRINCETON, N.J., March 3, 2015 /PRNewswire/ -- Soligenix, Inc.
Researchers at MIT have developed a new device which uses nanoparticles to block the genes that confers drug resistance, offering a new way to prevent chemotherapy and other treatments from losing their effectiveness in treating cancer over time.
Neulasta Delivery Kit Provides Administration Option for Patients who may not Otherwise Need to Return to Clinic or Hospital the day After Chemotherapy THOUSAND OAKS, Calif., March
DALLAS, March 2, 2015 /PRNewswire/ -- ReportsnReports.com adds Lonsurf and Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023 research report focuses on
NEW YORK, March 2, 2015 /PRNewswire/ -- Delcath Systems, Inc.
THOUSAND OAKS, Calif., Feb.
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...
- A person in a secondary role, specifically the second most important character (after the protagonist).